Zinc for the Treatment of COVID-19

Results from early COVID-19 studies are still emerging. Some micronutrients, such as zinc, have been shown to decrease the severity of viral infections yet human data is sparse. Join host, Geoff Wall, as he evaluates a new study looking at the proposed benefit of zinc in COVID-19 infections.The GameChangerZinc has several antiviral properties. A recent trial showed a decreased risk of ICU admission – however, has numerous exclusion criteria impacting the external validity.Show Segments00:00 - Introductions01:45 - Zinc Role In COVID-1904:20 - Looking at the Study10:33 - The GameChanger: Study Results19:03 - Connecting to Practice: Applicability of Exclusions21:48 - Closing RemarksHostGeoff Wall, PharmD, BCPS, FCCP, CGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthReferences and ResourcesTwice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial, Clinical Infectious DiseasesA Potential Role for Zinc to Enhance Treatment for Coronavirus Disease 2019 (COVID-19)Redeem your CPE or CME hereCPE (Pharmacist) CME (Physician) Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Pharmacists: Get a membershipPrescribers: Get a membershipCE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the putative role of zinc in treating COVID-192. Describe the application of the results of the Zinc COVID-19 study0.05 CEU/0.5 HrUAN: 0107-0000-23-025-H01-PInitial release date: 01/23/2023Expiration date: 01/23/2024Additional CPE and CME details can be found here.Follow CEimpact on Social Media:LinkedInInstagram